Replies to post #154 on The Medicines Company (MDCO)

[DewDiligence]

Would love to see MDCO license the EGRX product, but with a very full plate, and most sales reps transitioned to new product, it doesn't seem probable…

If they still have cath-lab reps, what are they selling that is more lucrative than EGRX’s ready-to-use Angiomax?

Need to re-listen to the CC to verify what seemed almost ridiculous potential anesthesia patient numbers, Europe and US combined.

So do I.